Table 2. Detailed antiretroviral drug resistance mutation profiles detected in 25 of the 277 pre-treatment patient samples.
| Sample ID | # NNRTI SDRMs | NNRTI SDRMs | # NRTI SDRMs | NRTI SDRMs | # PI SDRMs | PI SDRMs |
|---|---|---|---|---|---|---|
| GF-EC-A-013 | 1 | K103N | None | None | ||
| GF-EC-A-015 | 1 | K103N | None | None | ||
| GF-EC-A-020 | 1 | Y188L | None | None | ||
| GF-EC-A-018 | 1 | G190S | 1 | M184V | None | |
| GF-FS-A-001 | 1 | K103N | None | None | ||
| GF-FS-A-012 | 1 | L100I | None | None | ||
| GF-FS-A-007 | 3 | K103N, V106M, Y181C | 2 | K65R, D67N | None | |
| GF-GP-A-049 | 1 | K103N | None | None | ||
| GF-GP-A-034 | 1 | K103N | None | None | ||
| GF-GP-A-021 | 1 | Y181C | 1 | K65R | None | |
| GF-KZ-A-003 | 1 | V106M | None | None | ||
| GF-KZ-A-035 | 1 | K103N | None | None | ||
| GF-KZ-A-057 | 1 | K103N | None | None | ||
| GF-KZ-A-063 | 1 | K103N | None | None | ||
| GF-KZ-A-089 | 1 | K103N | None | None | ||
| GF-KZ-A-099 | 1 | K103N | None | None | ||
| GF-KZ-A-092 | 2 | K103N, Y181C | None | None | ||
| GF-KZ-A-111 | 2 | K103N, P225H | None | None | ||
| GF-KZ-A-073 | None | 1 | L210W | 1 | L90M | |
| GF-KZ-A-014 | 3 | K103N, V106M, M230L | 1 | K65R | None | |
| GF-KZ-A-051 | 3 | K101E, Y181C, G190A | 2 | K65R, M184V | None | |
| GF-LP-A-011 | 1 | Y181C | None | None | ||
| GF-MP-A-020 | 2 | K103N, Y181C | 6 | M41L, Y115F, F116Y, Q151M, M184V, T215Y | None | |
| GF-MP-A-009 | None | None | 1 | V32I | ||
| GF-NW-A-003 | 1 | K103N | None | None |
Samples highlighted in grey might not represent true ART naïve patients.